Soviero Asset Management’s Gilead Sciences GILD Stock Holding History

Soviero Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$1.85M	–	55
2024 Q4	$1.85M	Sell	20,000 -3,000	-13%	-$270K	1.16%	36
2024 Q3	$1.93M	Buy	+23,000	New	+$1.76M	1.75%	28
2021 Q3	–	Sell	-90,000	Closed	-$6.2M	–	46
2021 Q2	$6.2M	Sell	90,000 -250,000	-74%	-$16.7M	0.55%	38
2021 Q1	$22M	Sell	340,000 -100,000	-23%	-$6.45M	1.75%	21
2020 Q4	$25.6M	Buy	+440,000	New	+$26.5M	5.91%	5

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Soviero Asset Management's GILD Position: Q1 2025 in Review

Soviero Asset Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 20,000 shares — an estimated $1.85M sold.

Soviero Asset Management first reported a position in GILD in Q4 2020 and held it in 5 quarters. The position peaked at $25.6M in Q4 2020. 2,012 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Soviero Asset Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Soviero Asset Management sold 20,000 Gilead Sciences shares in Q1 2025, an estimated $1.85M.
Soviero Asset Management first reported a position in Gilead Sciences in Q4 2020 and held it in 5 quarters.
Soviero Asset Management's Gilead Sciences position peaked at $25.6M in Q4 2020.
2,012 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Soviero Asset Management's 13F filing for Q1 2025, filed 15 May 2025.